SK

Sewon Kang

University of Michigan: 10 patents #137 of 4,352Top 4%
The Johns Hopkins University: 1 patents #1,892 of 4,416Top 45%
📍 Ann Arbor, MI: #689 of 6,071 inventorsTop 15%
🗺 Michigan: #6,947 of 86,293 inventorsTop 9%
Overall (All Time): #378,562 of 4,157,543Top 10%
13
Patents All Time

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
10758630 Topical compositions and methods of detection and treatment Jennifer L. Sample, Julia B. Patrone, Jason J. Benkoski, Jennifer L. Breidenich, Lisa A. Kelly +8 more 2020-09-01
7795302 Use of compositions for treating rosacea John J. Voorhees, Gary Fisher 2010-09-14
7268148 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes John J. Voorhees, Gary Fisher 2007-09-11
7147863 UVA (> 360-400) and UVB (300-325) specific sunscreens Gary Fisher, John J. Voorhees 2006-12-12
7078048 Method and compositions for treating rosacea John J. Voorhees, Gary Fisher 2006-07-18
6942870 Compositions and methods using direct MMP inhibitors for inhibiting photoaging of skin Gary Fisher, John J. Voorhees 2005-09-13
6919072 Methods and compositions for reducing collagen loss due to chronological aging in human skin James Varani, Gary Fisher, John J. Voorhees 2005-07-19
6638543 Use of natural EGFR inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth factor receptor Gary Fisher, John J. Voorhees 2003-10-28
6630516 Methods and compositions for preventing and treating chronological aging in human skin James Varani, Gary Fisher, John J. Voorhees 2003-10-07
6365630 Compositions and methods for inhibiting photoaging of skin Gary Fisher, John J. Voorhees 2002-04-02
6130254 Methods for inhibiting photoaging of skin Gary Fisher, John J. Voorhees 2000-10-10
5998393 Methods for assessing 1,25(OH).sub.2 D.sub.3 activity in skin and for enhancing the therapeutic use of 1,25(OH).sub.2 D.sub.3 John J. Voorhees, Geert Cauwenbergh 1999-12-07
5998394 Compositions for treating skin conditions by enhancing the activity of 1,25(OH).sub.2 D.sub.3 using an RXR ligand and/or a 24-hydroxylase inhibitor John J. Voorhees, Geert Cauwenbergh 1999-12-07